AHLIN C[au] - Search Results

Year	Number of Results
2006	2
2007	1
2008	1
2009	1
2010	3
2011	2
2012	5
2013	4
2014	3
2015	3
2016	1
2017	3
2020	1
2024	0

1

Restricted cubic splines for modelling periodic data.

Lusa L, Ahlin Č. Lusa L, et al. Among authors: ahlin c. PLoS One. 2020 Oct 28;15(10):e0241364. doi: 10.1371/journal.pone.0241364. eCollection 2020. PLoS One. 2020. PMID: 33112926 Free PMC article.

2

Nuclear osteopontin-c is a prognostic breast cancer marker.

Zduniak K, Ziolkowski P, Ahlin C, Agrawal A, Agrawal S, Blomqvist C, Fjällskog ML, Weber GF. Zduniak K, et al. Among authors: ahlin c. Br J Cancer. 2015 Feb 17;112(4):729-38. doi: 10.1038/bjc.2014.664. Epub 2015 Jan 27. Br J Cancer. 2015. PMID: 25625274 Free PMC article.

3

Natural history of recurrences in endometrial carcinoma.

Sorbe B, Juresta C, Ahlin C. Sorbe B, et al. Among authors: ahlin c. Oncol Lett. 2014 Oct;8(4):1800-1806. doi: 10.3892/ol.2014.2362. Epub 2014 Jul 18. Oncol Lett. 2014. PMID: 25202413 Free PMC article.

4

Inflammatory cells in node-negative breast cancer.

Löfdahl B, Ahlin C, Holmqvist M, Holmberg L, Zhou W, Fjällskog ML, Amini RM. Löfdahl B, et al. Among authors: ahlin c. Acta Oncol. 2012 May;51(5):680-6. doi: 10.3109/0284186X.2011.652737. Epub 2012 Jan 24. Acta Oncol. 2012. PMID: 22268578

5

Ghrelin is a prognostic marker and a potential therapeutic target in breast cancer.

Grönberg M, Ahlin C, Naeser Y, Janson ET, Holmberg L, Fjällskog ML. Grönberg M, et al. Among authors: ahlin c. PLoS One. 2017 Apr 18;12(4):e0176059. doi: 10.1371/journal.pone.0176059. eCollection 2017. PLoS One. 2017. PMID: 28419141 Free PMC article.

6

Assessing nursing students' knowledge and skills in performing venepuncture and inserting peripheral venous catheters.

Ahlin C, Klang-Söderkvist B, Johansson E, Björkholm M, Löfmark A. Ahlin C, et al. Nurse Educ Pract. 2017 Mar;23:8-14. doi: 10.1016/j.nepr.2017.01.003. Epub 2017 Jan 27. Nurse Educ Pract. 2017. PMID: 28171853

7

[Ki-67 and cyclin A--prognostic factors in breast cancer. Time to introduce proliferation markers in clinical routine].

Ahlin C, Fernö M, Amini RM, Tolockiene E, Blomqvist C, Bergh J, Fjällskog ML. Ahlin C, et al. Lakartidningen. 2010 Mar 10-16;107(10):672-5. Lakartidningen. 2010. PMID: 20402250 Review. Swedish. No abstract available.

8

High proliferation is associated with inferior outcome in male breast cancer patients.

Nilsson C, Koliadi A, Johansson I, Ahlin C, Thorstenson S, Bergkvist L, Hedenfalk I, Fjällskog ML. Nilsson C, et al. Among authors: ahlin c. Mod Pathol. 2013 Jan;26(1):87-94. doi: 10.1038/modpathol.2012.145. Epub 2012 Aug 24. Mod Pathol. 2013. PMID: 22918167 Free article.

9

Molecular subtyping of male breast cancer using alternative definitions and its prognostic impact.

Nilsson C, Johansson I, Ahlin C, Thorstenson S, Amini RM, Holmqvist M, Bergkvist L, Hedenfalk I, Fjällskog ML. Nilsson C, et al. Among authors: ahlin c. Acta Oncol. 2013 Jan;52(1):102-9. doi: 10.3109/0284186X.2012.711952. Epub 2012 Aug 29. Acta Oncol. 2013. PMID: 22928693

10

Development of instruments for assessment of knowledge and skills in performing venepuncture and inserting peripheral venous catheters.

Ahlin C, Löfmark A, Klang-Söderkvist B, Johansson E. Ahlin C, et al. J Vasc Access. 2013 Oct-Dec;14(4):364-72. doi: 10.5301/jva.5000147. Epub 2013 Apr 10. J Vasc Access. 2013. PMID: 23599136

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

26 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year